Shots:
- Tyris to receive up front, research milestone along with research funding and will be responsible for generating clinical lead candidates and will further progress them to clinical development
- Almirall to get an exclusive option to acquire gene therapies and progress them through clinical development to commercialization
- The collaboration will integrate Tyris’s non-viral based gene therapy technology and Almirall’s expertise in medical dermatology. The alliance will focus on developing next-generation gene therapies with transformational potential for rare genetic dermatology diseases
Click here to read full press release/ article | Ref: PRNewswire | Image: Nature
The post Almirall and Tyris Collaborate to Develop Next Generation Gene Therapies first appeared on PharmaShots.
